NKLR

Terra Innovatum Global N.V. (NKLR) - Q2 2026 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2026. Terra Innovatum Global N.V. is a development-stage nuclear energy technology company incorporated in the Netherlands with principal offices in Italy. The company is focused on the engineering design, regulatory engagement, and supply chain planning for its SOLO™ Micro-Modular Nuclear Reactor, a gas-cooled system designed to generate 1 MWe of baseload power. The company completed a business combination with GSR III Acquisition Corp. in October 2025 and is currently listed on Nasdaq. As of the reporting date, the company has not generated revenue from operations.

Key Financial Metrics

Note: All amounts in thousands of USD unless otherwise specified.

Material Changes vs. Prior Period

• Net Loss Expansion: Net loss for the three months ended June 30, 2026, increased to $18.0 million from $1.1 million in the same period in 2025. The six-month net loss increased to $25.2 million from $2.6 million.
• Operating Expenses: Total operating expenses rose 181% quarter-over-quarter to $6.1 million. General and administrative expenses increased by $2.5 million (119%), driven by higher consulting fees, insurance, and board compensation. Development costs surged 2,545% to $1.5 million due to increased technical consultancy fees.
• Non-Cash Fair Value Adjustments: A significant driver of the loss was a $12.5 million unrealized loss on the change in fair value of the share-settled contingent liability (related to vesting milestones) and a $0.7 million loss on warrant liabilities. These items were non-existent or gains in the prior year.
• Cash Position: Cash and cash equivalents decreased by $11.8 million from December 31, 2025 ($102.9 million) to June 30, 2026 ($91.1 million), primarily due to operating cash burn of $8.8 million and foreign exchange effects.

Outlook, Risks, and Management Commentary

• Commercialization Timeline: Management targets commercial deployment of the SOLO reactor by 2028. The company has completed conceptual and detailed design phases and initiated pre-application engagement with the U.S. Nuclear Regulatory Commission (NRC).
• Liquidity: The company relies on existing cash resources ($91.1 million) to fund operations. Management anticipates the need for additional capital to complete development and achieve commercialization. There is no assurance that financing will be available on acceptable terms.
• Internal Control Weaknesses: Management concluded that disclosure controls and procedures were not effective as of June 30, 2026, due to four material weaknesses. These include insufficient Sarbanes-Oxley (SOX) control environment, lack of formal risk assessment post-de-SPAC, failure to uplift internal controls, and absence of a monitoring program. A remediation plan is underway.
• Risks: Key risks include the complexity of nuclear regulatory approval, dependence on external funding, global supply chain vulnerabilities, and the sensitivity of fair value measurements for contingent liabilities to stock price volatility.

Investor Verification Checklist

• Cash Runway: Verify the sufficiency of the $91.1 million cash balance against the projected burn rate to reach the 2028 commercialization target.
• Regulatory Milestones: Monitor progress of the pre-application engagement with the NRC, as delays could significantly impact the timeline and funding requirements.
• Contingent Liability Volatility: Review the valuation assumptions (volatility, probability of milestones) for the $196.5 million share-settled contingent liability, as changes here will materially impact reported net income without affecting cash flow.
• Remediation of Internal Controls: Track the implementation of the remediation plan for the identified material weaknesses in internal controls over financial reporting.
• Capital Raising: Assess the company's ability to raise additional equity or debt given the current market conditions and the company's pre-revenue status.